chrX-13746826-C-CA

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_003611.3(OFD1):​c.710dupA​(p.Tyr238ValfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000653 in 1,071,252 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000065 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

OFD1
NM_003611.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 1.15

Publications

11 publications found
Variant links:
Genes affected
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
OFD1 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 10
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • orofaciodigital syndrome I
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 23
    Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Simpson-Golabi-Behmel syndrome type 2
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant X-13746826-C-CA is Pathogenic according to our data. Variant chrX-13746826-C-CA is described in ClinVar as Pathogenic. ClinVar VariationId is 41143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OFD1NM_003611.3 linkc.710dupA p.Tyr238ValfsTer2 frameshift_variant Exon 8 of 23 ENST00000340096.11 NP_003602.1 O75665-1E9KL37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OFD1ENST00000340096.11 linkc.710dupA p.Tyr238ValfsTer2 frameshift_variant Exon 8 of 23 1 NM_003611.3 ENSP00000344314.6 O75665-1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
106946
Hom.:
0
Cov.:
23
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000659
AC:
1
AN:
151766
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000653
AC:
7
AN:
1071252
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
345768
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
25390
American (AMR)
AF:
0.0000299
AC:
1
AN:
33435
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18806
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29639
South Asian (SAS)
AF:
0.00
AC:
0
AN:
50974
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40104
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4034
European-Non Finnish (NFE)
AF:
0.00000728
AC:
6
AN:
823911
Other (OTH)
AF:
0.00
AC:
0
AN:
44959
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.239
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
106946
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
30650
African (AFR)
AF:
0.00
AC:
0
AN:
29316
American (AMR)
AF:
0.00
AC:
0
AN:
10054
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2582
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3478
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2472
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5176
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
51539
Other (OTH)
AF:
0.00
AC:
0
AN:
1427
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Orofaciodigital syndrome I Pathogenic:2
Feb 23, 2023
3billion
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000041143 / PMID: 12595504). The variant was detected at ~19% allele frequency and was identified as a potential mosaic variant. Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Feb 02, 2022
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with orofaciodigital syndrome I (MIM#311200). (I) 0110 - This gene is associated with X-linked disease. Most conditions associated with this gene are X-linked recessive, however orofaciodigital syndrome I (MIM#311200) is X-linked dominant. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many other variants predicted to result in a loss of function have previously been reported in individuals with orofaciodigital syndrome I (MIM#311200) (ClinVar, DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The variant has previously been reported in multiple individuals with orofaciodigital syndrome I (MIM#311200), with both de novo and familial inheritance (HGMD, LOVD, PMID: 18546297). (SP) 1101 - Very strong and specific phenotype match for this individual. (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed, by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

not provided Pathogenic:2
Jan 05, 2023
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 18, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Also known as 702insA using alternate nomenclature; This variant is associated with the following publications: (PMID: 18546297, 19876934, 12595504) -

Simpson-Golabi-Behmel syndrome Pathogenic:1
Oct 04, 2024
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

PVS1, PM2, PP4, PS2 -

OFD1-related disorder Pathogenic:1
May 08, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The OFD1 c.710dupA variant is predicted to result in a frameshift and premature protein termination (p.Tyr238Valfs*2). This variant was reported in individuals with oral-facial-digital syndrome I (see for example, reported as 702insA at Romio et al. 2003. PubMed ID: 12595504 with clinical information at Feather et al. 1997. PubMed ID: 9215688; de novo at Table S6 of El Naofal et al. 2023. PubMed ID: 36703223). This variant is reported in 0.0071% of alleles in individuals of South Asian descent in gnomAD. Frameshift variants in OFD1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Retinitis pigmentosa 23;C1510460:Orofaciodigital syndrome I;C1846175:Simpson-Golabi-Behmel syndrome type 2;C2749019:Joubert syndrome 10 Pathogenic:1
Dec 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=1/199
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.37
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.37
Position offset: -46

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs312262845; hg19: chrX-13764945; COSMIC: COSV60796643; API